Inhibitors of soluble epoxide hydrolase on acute lung injury: a meta-analysis of preclinical studies.

Tao, Wei; Xu, Gang; Luo, Yi; Li, Ping-Song

Tao, Wei; Xu, Gang; Luo, Yi; Li, Ping-Song.

Afiliación

Tao W; Department of Burn and Plastic Surgery, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, No. 98, Nantong West Road, Yangzhou, Jiangsu, China.
Xu G; Department of Burn and Plastic Surgery, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, No. 98, Nantong West Road, Yangzhou, Jiangsu, China.
Luo Y; Department of Burn and Plastic Surgery, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, No. 98, Nantong West Road, Yangzhou, Jiangsu, China.
Li PS; Department of Burn and Plastic Surgery, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, No. 98, Nantong West Road, Yangzhou, Jiangsu, China. yzzxmrlps@qq.com.

Inflammopharmacology ; 30(6): 2027-2033, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36085400

Asunto(s)

Lesión Pulmonar Aguda; Síndrome de Dificultad Respiratoria; Animales; Epóxido Hidrolasas; Lesión Pulmonar Aguda/tratamiento farmacológico; Síndrome de Dificultad Respiratoria/tratamiento farmacológico; Pulmón; Inhibidores Enzimáticos

Palabras clave

Acute lung injury; Inhibitors; Mortality; soluble epoxide hydrolase

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Dificultad Respiratoria / Lesión Pulmonar Aguda Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Animals Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google